Maxcyte Stock Price on August 9, 2024
| MXCT Stock | USD 3.55 0.03 0.85% |
If you're considering investing in MaxCyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of MaxCyte stands at 3.55, as last reported on the 1st of December, with the highest price reaching 3.62 and the lowest price hitting 3.46 during the day. MaxCyte has Sharpe Ratio of -0.0512, which conveys that the firm had a -0.0512% return per unit of risk over the last 3 months. MaxCyte exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MaxCyte's Mean Deviation of 2.48, standard deviation of 3.29, and Risk Adjusted Performance of (0.04) to check out the risk estimate we provide.
At this time, MaxCyte's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 281.7 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 222.4 M in 2024. . At this time, MaxCyte's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.20 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.13). MaxCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
MaxCyte |
Sharpe Ratio = -0.0512
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MXCT |
Estimated Market Risk
| 3.27 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MaxCyte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MaxCyte by adding MaxCyte to a well-diversified portfolio.
Price Book 1.7556 | Enterprise Value Ebitda (11.07) | Price Sales 8.2121 | Shares Float 96.5 M | Wall Street Target Price 9.25 |
Related Headline
Anika Therapeutics Headline on 9th of August 2024
Anika Therapeutics, Inc. Are Hedge Funds Bullish on This Cal... by finance.yahoo.com
We recently compiled a list of the Top 10 Holdings of Caligan Partners. In this article, we are going to take a look at where Anika Therapeutics, Inc. stands against Caligan Partners other top holdings. Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds. David Johnson is the brainchild behind
MaxCyte Valuation on August 9, 2024
It is possible to determine the worth of MaxCyte on a given historical date. On August 9, 2024 MaxCyte was worth 4.16 at the beginning of the trading date compared to the closed value of 4.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MaxCyte stock. Still, in general, we apply an absolute valuation method to find MaxCyte's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MaxCyte where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MaxCyte's related companies.
| Open | High | Low | Close | Volume | |
| 4.16 | 4.35 | 4.10 | 4.18 | 451,278 | |
08/09/2024 | 4.16 | 4.29 | 4.06 | 4.18 | 369,615 |
| 4.19 | 4.41 | 4.01 | 4.03 | 364,086 |
| Backtest MaxCyte | | | MaxCyte History | | | MaxCyte Valuation | Previous | Next |
MaxCyte Trading Date Momentum on August 9, 2024
| On August 12 2024 MaxCyte was traded for 4.03 at the closing time. The top price for the day was 4.41 and the lowest listed price was 4.01 . The trading volume for the day was 364.1 K. The trading history from August 12, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.59% . The trading delta at closing time against the current closing price is 1.44% . |
MaxCyte Fundamentals Correlations and Trends
By evaluating MaxCyte's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MaxCyte's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MaxCyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About MaxCyte Stock history
MaxCyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MaxCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MaxCyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MaxCyte stock prices may prove useful in developing a viable investing in MaxCyte
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 103.3 M | 66.8 M | |
| Net Loss | -21.2 M | -22.3 M |
MaxCyte Quarterly Net Working Capital |
|
MaxCyte Stock Technical Analysis
MaxCyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
MaxCyte Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
MaxCyte cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
MaxCyte December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how MaxCyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MaxCyte shares will generate the highest return on investment. By undertsting and applying MaxCyte stock market strength indicators, traders can identify MaxCyte entry and exit signals to maximize returns
MaxCyte Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MaxCyte's price direction in advance. Along with the technical and fundamental analysis of MaxCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MaxCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.16) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for MaxCyte Stock Analysis
When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.